Literature DB >> 17101146

Ionic basis of ischemia-induced bradycardia in the rabbit sinoatrial node.

Yi-Mei Du1, Richard D Nathan.   

Abstract

To investigate the basis of ischemia-induced bradycardia (<60 beats/min), we isolated pacemaker cells from the rabbit sinoatrial node and exposed them to ischemic-like conditions, including omission of glucose, pH 6.6, and either 5.4 or 10 mM KCl to evaluate the role of increased serum [K]. A perforated-patch technique was employed to test the hypothesis that the arrhythmia is caused by attenuation of inward currents that contribute to the diastolic depolarization. After exposure to "ischemic" Tyrode containing 5.4 mM KCl, the pacemaker cells exhibited 13% slower beat rates and action potentials with 6-mV greater overshoots and 44% longer durations. In contrast, after exposure to "ischemic" Tyrode containing 10 mM KCl, the pacemaker cells exhibited a 7-mV depolarization of the maximum diastolic potential but no significant change in the overshoot. Beat rates were slowed by 43%, and the action potentials were prolonged by 46%. "Ischemic" Tyrode containing 5.4 mM KCl increased L-type Ca current, decreased T-type Ca current and reduced Ni-sensitive inward current tails (presumably Na-Ca exchange current), even after treatment with 40 muM ryanodine to block Ca release from the sarcoplasmic reticulum. "Ischemic" Tyrode containing 10 mM KCl increased hyperpolarization-activated inward current at diastolic potentials and reduced the slowly activating component, but not the rapidly activating component, of delayed rectifier K current. Our results suggest that reductions of inward Na-Ca exchange current and T-type Ca current contribute to "ischemia"-induced "bradycardia" in sinoatrial node pacemaker cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101146     DOI: 10.1016/j.yjmcc.2006.10.004

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

1.  Cardiac pacemaker cell failure with preserved I(f), I(CaL), and I(Kr): a lesson about pacemaker function learned from ischemia-induced bradycardia.

Authors:  Victor A Maltsev; Edward G Lakatta
Journal:  J Mol Cell Cardiol       Date:  2006-12-22       Impact factor: 5.000

Review 2.  Normal heart rhythm is initiated and regulated by an intracellular calcium clock within pacemaker cells.

Authors:  Victor A Maltsev; Edward G Lakatta
Journal:  Heart Lung Circ       Date:  2007-09-10       Impact factor: 2.975

3.  Impaired signaling intrinsic to sinoatrial node pacemaker cells affects heart rate variability during cardiac disease.

Authors:  Yael Yaniv; Alexey E Lyashkov; Edward G Lakatta
Journal:  J Clin Trials       Date:  2014-03

4.  The involvement of TRPC3 channels in sinoatrial arrhythmias.

Authors:  Yue-Kun Ju; Bon Hyang Lee; Sofie Trajanovska; Gouliang Hao; David G Allen; Ming Lei; Mark B Cannell
Journal:  Front Physiol       Date:  2015-03-25       Impact factor: 4.566

Review 5.  Altered Calcium Handling and Ventricular Arrhythmias in Acute Ischemia.

Authors:  Peter Baumeister; T Alexander Quinn
Journal:  Clin Med Insights Cardiol       Date:  2016-12-14

6.  Activation of transient receptor potential vanilloid 4 involves in hypoxia/reoxygenation injury in cardiomyocytes.

Authors:  Qiong-Feng Wu; Cheng Qian; Ning Zhao; Qian Dong; Jing Li; Bin-Bin Wang; Lei Chen; Lixiu Yu; Bing Han; Yi-Mei Du; Yu-Hua Liao
Journal:  Cell Death Dis       Date:  2017-05-25       Impact factor: 8.469

Review 7.  Impact of Chronic Fetal Hypoxia and Inflammation on Cardiac Pacemaker Cell Development.

Authors:  Martin G Frasch; Dino A Giussani
Journal:  Cells       Date:  2020-03-17       Impact factor: 6.600

8.  Di-4-ANEPPS Modulates Electrical Activity and Progress of Myocardial Ischemia in Rabbit Isolated Heart.

Authors:  Marina Ronzhina; Tibor Stracina; Lubica Lacinova; Katarina Ondacova; Michaela Pavlovicova; Lucie Marsanova; Radovan Smisek; Oto Janousek; Katerina Fialova; Jana Kolarova; Marie Novakova; Ivo Provaznik
Journal:  Front Physiol       Date:  2021-06-10       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.